A common promoter hypomethylation signature in invasive breast, liver and prostate cancer cell lines reveals novel targets involved in cancer invasiveness.

Oncotarget · 2015 · PMC4741763 · PMID 26427334

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Our analysis revealed a strong highly significant common DNA methylation signature that differentiates invasive from non-invasive cancer cells in spite of their vastly different tissues of origin.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.